Boston Scientific Beats Q2—but Trims FY Outlook as Q3 Guidance Misses

‼️ BREAKING: Boston Scientific Q2 2026 Earnings: Adj EPS 86C (Est 83C); Net Sales $5.44B (Est $5.36B); Sees Q3 Adj EPS 80C To 82C (Est 84C); Sees FY Adj EPS $3.28 To $3.32, Saw $3.34 To $3.41; Sees FY Organic Net Sales 5% To 6%

Leave a comment